The most common method of managing pain is the use of opioids like morphine, oxycodone, and fentanyl, all of which are highly addictive. Research has shown that therapeutic exposure to low-intensity green light can reverse chronic pain.

The University of Arizona has exclusively licensed the rights to a novel kinase inhibitor, which is efficacious for the treatment of a variety of solid tumors in canines, to Anivive Lifesciences.

At the Get Started Tucson business pitch competition, judges selected just eight teams out of a pool of 69 applicant companies to pitch at the Tucson version of ABC’s Shark Tank. Of those, two were companies working to commercialize technologies invented at the UA.

Cryptosporidium is a protozoan parasite that lives in the intestine and is a major cause of moderate-to-severe diarrhea in humans and livestock worldwide. Michael Riggs, DVM, PhD, DACVP, has developed monoclonal antibodies capable of detecting Cryptosporidium antigens.

UA researchers, in collaboration with the University of California San Francisco, have developed a new treatment for acute myeloid leukemia. The team has formed a startup – Promutech Pharmaceuticals, Inc. – to further develop and commercialize the treatment.

The UA, through TLA, has partnered with TechCode, a global network of startup incubators and entrepreneurial ecosystems. TechCode will provide networking resources to increase the reach and effectiveness of TLA’s technology innovations and startups.

UPDATE: This year, we initially reported our results on August 30. Regrettably, on September 30, we discovered that two FY2016 agreements were misclassified in our system. We've since updated our process and documents.

For the OSIRIS-REx asteroid sample return mission that the University of Arizona is leading, researchers developed the OSIRIS-REx Camera Suite (OCAMS). One of the cameras, PolyCam, has a novel roller screw designed to meet the accuracy, reliability, and power requirements that the mission demands.

Last year, we described how we are connecting people, resources and ideas to build a new kind of commercialization ecosystem. This year, we have broadened our work and deepened our reach, resulting in TLA's third year running of record results for the UA.

To address the growing number of inventions TLA evaluates for commercialization and help startups develop high-quality strategies and teams, the office has hired entrepreneur and executive Steven Wood for its Mentors-in-Residence team.